Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
AprioMed AB
AB
Active
Org 5565819249
Virdings Allé 28, 754 50
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 1999 · 26 years old
8 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
AprioMed AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
55M
41M
27M
14M
0M
2021: 29M
29M
2021
2022: 31M (+7% vs 2021)
31M
+7%
2022
2023: 36M (+16% vs 2022)
36M
+16%
2023
2025: 44M (+22% vs 2023)
44M
+22%
2025
2026: 32M (-27% vs 2025)
32M
-27%
2026
EBITDA
SEK millions
12M
9M
6M
3M
0M
2021: 9M
9M
2021
2022: 10M (+11% vs 2021)
10M
+11%
2022
2023: 8M (-20% vs 2022)
8M
-20%
2023
2025: 8M (0% vs 2023)
8M
0%
2025
2026: 2M (-75% vs 2025)
2M
-75%
2026
Income statement
SEK thousands
Item
2026
2025
2023
2022
2021
Revenue
32 200
44 214
35 774
30 972
29 139
Staff expenses
−9 105
—
—
—
—
EBITDA
2 101
7 602
7 976
10 300
8 961
Depreciation & amort.
−347
−330
−210
−201
−224
EBIT
1 754
7 272
7 766
10 099
8 737
Net financials
42
633
31 446
61
25
Profit before tax
1 796
7 904
39 212
10 160
10 462
Tax
422
−875
−1 148
−1 670
−1 406
Net profit
2 218
7 029
38 064
8 490
9 056
Balance sheet
SEK thousands
Item
2026
2025
2023
2022
2021
Total assets
24 489
25 113
54 296
26 796
28 661
Equity
22 593
23 375
51 899
25 340
24 851
Long-term debt
—
0
0
0
0
Short-term debt
1 896
1 739
2 397
1 456
3 810
Total debt
1 896
1 739
2 397
1 456
3 810
Financial ratios
5-year trend
EBITDA margin
6,5 %
This company
15,8 %
Market median
This company
Market median
59% below market
2021
2026
Equity ratio
92,3 %
This company
38,2 %
Market median
This company
Market median
142% above market
2021
2026
Return on equity
9,8 %
This company
18,4 %
Market median
This company
Market median
47% below market
2021
2026
Net profit margin
6,9 %
This company
8,1 %
Market median
This company
Market median
15% below market
2021
2026
Asset turnover
1,31×
This company
1,12×
Market median
This company
Market median
17% above market
2021
2026
Debt / equity
0,08×
This company
0,62×
Market median
This company
Market median
87% below market
2021
2026
Annual reports & filings
Annual report 2026
Filed via Bolagsverket / SCB · Period 2025-04-01 – 2026-03-31
View
PDF
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2025-03-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on AprioMed AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
